16-11254849-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003745.2(SOCS1):​c.630G>C​(p.Gln210His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00885 in 1,478,218 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q210R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0053 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0093 ( 69 hom. )

Consequence

SOCS1
NM_003745.2 missense

Scores

6
13

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 1.92

Publications

23 publications found
Variant links:
Genes affected
SOCS1 (HGNC:19383): (suppressor of cytokine signaling 1) This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by a subset of cytokines, including IL2, IL3 erythropoietin (EPO), CSF2/GM-CSF, and interferon (IFN)-gamma. The protein encoded by this gene functions downstream of cytokine receptors, and takes part in a negative feedback loop to attenuate cytokine signaling. Knockout studies in mice suggested the role of this gene as a modulator of IFN-gamma action, which is required for normal postnatal growth and survival. [provided by RefSeq, Jul 2008]
RMI2 (HGNC:28349): (RecQ mediated genome instability 2) RMI2 is a component of the BLM (RECQL3; MIM 604610) complex, which plays a role in homologous recombination-dependent DNA repair and is essential for genome stability (Xu et al., 2008 [PubMed 18923082]).[supplied by OMIM, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009278804).
BP6
Variant 16-11254849-C-G is Benign according to our data. Variant chr16-11254849-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 135275.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00534 (813/152302) while in subpopulation NFE AF = 0.00922 (627/68018). AF 95% confidence interval is 0.00862. There are 4 homozygotes in GnomAd4. There are 335 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 813 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SOCS1NM_003745.2 linkc.630G>C p.Gln210His missense_variant Exon 2 of 2 ENST00000332029.4 NP_003736.1 O15524Q4JHT5
LOC105371082XR_933070.4 linkn.178+5071C>G intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SOCS1ENST00000332029.4 linkc.630G>C p.Gln210His missense_variant Exon 2 of 2 1 NM_003745.2 ENSP00000329418.2 O15524

Frequencies

GnomAD3 genomes
AF:
0.00534
AC:
813
AN:
152184
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00241
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00922
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00498
AC:
642
AN:
128918
AF XY:
0.00487
show subpopulations
Gnomad AFR exome
AF:
0.00239
Gnomad AMR exome
AF:
0.00154
Gnomad ASJ exome
AF:
0.000771
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00227
Gnomad NFE exome
AF:
0.00802
Gnomad OTH exome
AF:
0.00421
GnomAD4 exome
AF:
0.00925
AC:
12270
AN:
1325916
Hom.:
69
Cov.:
32
AF XY:
0.00882
AC XY:
5773
AN XY:
654216
show subpopulations
African (AFR)
AF:
0.00151
AC:
39
AN:
25874
American (AMR)
AF:
0.00142
AC:
29
AN:
20414
Ashkenazi Jewish (ASJ)
AF:
0.000536
AC:
10
AN:
18660
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32574
South Asian (SAS)
AF:
0.000632
AC:
41
AN:
64904
European-Finnish (FIN)
AF:
0.00234
AC:
116
AN:
49476
Middle Eastern (MID)
AF:
0.000191
AC:
1
AN:
5222
European-Non Finnish (NFE)
AF:
0.0111
AC:
11753
AN:
1054722
Other (OTH)
AF:
0.00520
AC:
281
AN:
54070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
653
1306
1959
2612
3265
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
504
1008
1512
2016
2520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00534
AC:
813
AN:
152302
Hom.:
4
Cov.:
33
AF XY:
0.00450
AC XY:
335
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00241
AC:
100
AN:
41572
American (AMR)
AF:
0.00242
AC:
37
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00217
AC:
23
AN:
10614
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00922
AC:
627
AN:
68018
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
45
89
134
178
223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00815
Hom.:
2
Bravo
AF:
0.00571
TwinsUK
AF:
0.0111
AC:
41
ALSPAC
AF:
0.0158
AC:
61
ESP6500AA
AF:
0.00229
AC:
10
ESP6500EA
AF:
0.00854
AC:
73
ExAC
AF:
0.00435
AC:
525
Asia WGS
AF:
0.000577
AC:
3
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RMI2: BS2; SOCS1: BS2 -

Jul 20, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.53
D;D
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.57
.;T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.0093
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L;L
PhyloP100
1.9
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.7
N;.
REVEL
Benign
0.059
Sift
Benign
0.068
T;.
Sift4G
Benign
0.065
T;.
Polyphen
0.97
D;D
Vest4
0.14
MutPred
0.12
Gain of helix (P = 0.0325);Gain of helix (P = 0.0325);
MVP
0.66
MPC
1.5
ClinPred
0.012
T
GERP RS
4.4
Varity_R
0.15
gMVP
0.46
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11549428; hg19: chr16-11348706; COSMIC: COSV59659165; API